Prediction of Adverse Outcome Using Fetal MRI in Pregnancies at Risk of Preterm Birth

Preterm Birth Complication Clinical Trial

Official title:

Individualised Risk Prediction of Adverse Neonatal Outcome in Pregnancies That Deliver Preterm Using Advanced MRI Techniques and Machine Learning

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05164432
• Other study ID #: 1121988
• Status: Recruiting
• Phase: N/A
• Start date: December 1, 2021
• Est. completion date: November 1, 2025

Study information

• Verified date: October 2023
• Source: King's College London
• Contact: Lisa Story, MD PhD
• Phone: 020 7188 7083
• Email: lisa.story[@]kcl.ac.uk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

1.4% of babies have a very premature birth (PTB) (less than 32 weeks of pregnancy). This can result in severe life-long complications including cerebral palsy, learning and behavioural difficulties and breathing problems. This has significant cost implications for the NHS, education services and immeasurable human costs for the child and their family.

Early delivery may result from maternal infection or poor attachment of the placenta to the womb, which may also cause abnormal brain and lung development. Even where obvious signs of infection are not present in the mother, subtle infection is often present in the baby. Currently there is no test routinely used to see if there is an infection of the baby inside the womb, and it is unknown how the placenta develops in babies that subsequently deliver preterm.

Using MRI, the investigators will assess the baby's thymus and placenta for signs of infection and assess how the lungs and brain are developing whilst still in the womb. Machine learning techniques, where computers analyze all the results together, will then be used to see if these scans can identify babies that do poorly after birth.

137 pregnant women at high risk of PTB (between 16-32 weeks of pregnancy) and 183 women with uncomplicated pregnancies will be invited to participate.

Women will have an MRI scan of the fetus assessing the lung, brain, thymus and placenta. Where high risk women do not deliver, repeat imaging will be offered every two weeks (maximum 3).

After birth the investigators will see if infection was present by analysing the placenta under a microscope, and see how the baby does. All the information from scans and after birth will be put into a computer, to predict which babies do poorly after birth. Health records of the child will be accessed up to two years of age.

Description:

1.4% of babies have a very premature birth (PTB) (less than 32 weeks of pregnancy). This can result in severe life-long complications including cerebral palsy, learning and behavioural difficulties and breathing problems. Besides immeasurable human costs for the baby and family this also has significant cost implications for the NHS.

Infection may cause both early delivery and subsequent abnormal brain and lung development. Where obvious signs of infection are not present in the mother, subtle infection is often present in the unborn baby. Currently there is no test routinely used to see if there is an infection of the baby in the womb.

Fetal Magnetic Resonance Imaging (MRI), already used in clinical practice, can produce very clear images of the baby's brain and lungs. It can also assess blood flow and structure in detail, as well as overall size. The investigators already have data, which shows areas of the brain and lungs are smaller in babies that subsequently deliver very preterm, indicating factors that drive preterm birth may already be affecting how the baby develops in the womb.

MRI can also give information regarding infection in the fetus by measuring an organ in the neck (the thymus) vital to the baby's immune system and by scanning the placenta. The investigators have new data that suggests that these methods could help pick up infection. Women who have previously undergone preterm birth have helped shape this study.

Aims The investigators want to ascertain if it is possible to predict which babies are likely to develop serious complications after preterm birth. Using MRI, the thymus and placenta will be assessed for signs of infection and how the lungs and brain are developing whilst still in the womb will be monitored. The investigators will evaluate if these scans accurately identify the babies that do poorly after birth.

Study Design 75 pregnant women at high risk of PTB (between 16- 32 weeks of pregnancy) and 100 women with uncomplicated pregnancies will be invited to participate.

Women will be identified as high-risk if:

1. they have no symptoms but are, attending the Preterm Surveillance Clinic at St Thomas's Hospital, with risk factors for PTB (a previous premature delivery or surgery to the neck of the womb (cervix)) and are likely to deliver early, which we can pick up by seeing if the cervix has already shortened, and by doing a vaginal swab test.

2. they have lost the fluid (waters) around the baby

3. the cervix has opened before 24 weeks These women will have an MRI scan of the fetal lung, brain, thymus and placenta. Repeat imaging will be offered every two weeks (maximum of three scans).

After birth the investigators will see if infection is present by analysing the umbilical cord blood and looking at the placenta under a microscope. Information about complications the babies have until they leave hospital will be collected.

All of this information, as well as from scans from healthy pregnant women involved in other research studies both in this country and from abroad, will be combined in a new test, using 'machine learning', which involves computers analysing the data to see if babies most likely to have problems after birth can be identified. Results will be presented in scientific papers, at conferences and through social media.

If the test works, the next step would be to find out when the best time is to deliver the baby; this may be sooner if the fetus is known to have an infection. The appropriate timing of existing treatments to prevent brain and lung injury may also be facilitated with more studies in the future.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 175
• Est. completion date: November 1, 2025
• Est. primary completion date: November 1, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• pregnant women with uncomplicated pregnancies 16-42 weeks pregnant OR

• pregnant women at high risk of preterm birth before 32 weeks gestation

Exclusion Criteria:

• inability to give informed consent

• multiple pregnancy

• gestational diabetes

• pre-eclampsia

• fetuses known to have chromosomal or fetal abnormalities

• a recently sited maternal metallic implant, claustrophobia.

Related Conditions & MeSH terms

• Premature Birth
• Preterm Birth Complication

Intervention

Diagnostic Test:
• MRI scan
Women will have an MRI scan during pregnancy to evaluate the fetus and placenta

Locations

Country	Name	City	State
United Kingdom	St Thomas' Hospital, King's College London	London	Greater London

Sponsors (6)

Lead Sponsor	Collaborator
King's College London	Boston Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, Massachusetts Institute of Technology, National Institute for Health Research, United Kingdom, Phoenix Children's Hospital

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants with chorioamnionitis	Chorioamnionitis will be diagnosed on placental histology	After delivery (within approximately three months of recruitment depending on the gestation at delivery)
Primary	Neonatal morbidity	A composite neonatal adverse outcome will be created	Neonatal period post delivery (up to approximately seven months after recruitment depending on the gestation at delivery)
Secondary	Individual adverse neonatal outcomes	Specific neurological, respiratory, GI and individual systems adverse outcomes for the neonate	Neonatal period post delivery (up to approximately seven months after recruitment depending on the gestation at delivery)